ANXA1 and central nervous system cancer: In gliomas, ANXA1 expression significantly increased in poorly differentiated human primary gliomas compared with normal brain tissue or lower‐grade tumours, indicating that ANXA1 is associated with the development and progression of malignant glioma.10